Open access
Oct 2026
NOL11 is a novel prognostic biomarker associated with immune infiltration and tumor progression in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) remains a highly lethal malignancy, and the lack of reliable biomarkers for prognosis assessment and therapeutic guidance continues to limit effective clinical management. Nucleolar protein 11 (NOL11), an important regulator of ribosomal biogenesis and cellular homeostasis, has remained t...
Hong Xie, Sheng-Nan Wang, Xia-Yang Sheng et al.
· Oncology Letters · 0 citations